Navigation Links
New Study Published in New England Journal of Medicine Shows Investigational BIBF 1120 Demonstrated Positive Trend in Reducing Lung Function Loss in Idiopathic Pulmonary Fibrosis
Date:9/21/2011

uent in patients receiving 150 mg of BIBF 1120 twice daily than placebo and adverse events leading to discontinuation were mostly diarrhea, nausea and vomiting.

"People who suffer from IPF are in great need of a safe and effective treatment to preserve lung function so they can maintain physical activity and reduce the impact on their independence for as long as possible," said Luca Richeldi, MD, PhD, lead study author and director of the Research Centre for Rare Lung Diseases, University of Modena and Reggio Emilia, Modena, Italy. "The positive trends in slowing the decline in lung function over time, reducing the incidence of acute exacerbations and improving the quality of life with BIBF 1120 are a promising proof of concept."

BIBF 1120 received orphan-drug designation from the U.S. Food and Drug Administration in June 2011. Two pivotal phase III clinical trials are currently underway enrolling a total of 970 patients in 20 countries. The first patients entered the trials in April and May 2011, respectively. For more information about the phase III trials or to learn how to enroll, please visit clinicaltrials.gov (identifiers NCT01335464 and NCT01335477).

"The results of the phase II clinical trial for BIBF 1120 in IPF give us the confidence to continue assessing the compound's potential in phase III clinical trials," said Christopher Corsico, MD, MPH, senior vice president, Medicine and Regulatory, North America, Boehringer Ingelheim Pharmaceuticals, Inc. "Boehringer Ingelheim remains committed to identifying an effective treatment for IPF to help bridge the unmet therapeutic need for the thousands of people suffering from this fatal disease."

TOMORROW Data at ERS 2011 Annual Congress

The NEJM paper will be presented at the European Respiratory Society (ERS) 2011 Annual Congress on Monday, Sept. 26, 2011. Additional results of the TOMORROW trial will be presented during oral sessions at ERS on Sunday, Sept. 25, 2
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Lung Cancer Study Reveals Similar Outcomes for African-American and Caucasian Patients Treated With Alimta®
2. Studying Fluid Overflow in Patients With Devices
3. Prolia® (Denosumab) Phase 2 Extension Study Showed Continued Increase in Bone Mineral Density Over Eight Years of Treatment
4. Novartis Study Showed ACZ885 Provided Substantial Symptom Relief in 84% of Patients With the Most Serious Form of Childhood Arthritis
5. Data From QNEXA Sequel Study Featured at the 47th EASD Annual Meeting
6. The 62nd Annual Meeting of the American Association for the Study of Liver Diseases
7. Soligenix Announces Results of Recent Data Safety Monitoring Board Review for Phase 3 orBec® Study in Acute GI GVHD
8. First Patient Enrolled in SARcode Biosciences Pivotal Dry Eye Study of SAR 1118 Ophthalmic Solution
9. Inovio Pharmaceuticals Completes PENNVAX™-B HIV Vaccine Phase I Study, Demonstrates Best-in-Class T-Cell Immune Responses
10. Breast Health Study Advances Safety Profile for Soy-Based Natural S-equol Supplement Designed to Manage Menopause Symptoms
11. Neurocrine Biosciences Announces the Start of Phase II Study of Elagolix in Uterine Fibroids
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... , May 29, 2015  Haemonetics Corporation (NYSE: ... Chief Operating Officer, will present at the JMP Securities ... on June 23 rd , 2015 at 11:30am ... Mr. Davies, presentation live via webcast at: http://wsw.com/webcast/jmp27/hae ... HAE ) is a global healthcare company dedicated ...
(Date:5/29/2015)... , May 29, 2015  World-renowned prostate surgeon and ... findings on the benefit of MR/Ultrasound Fusion-Guided Biopsy ... "Our Prostate Cancer Center at Lenox Hill Hospital ... Biopsy System in New York City . ... low risk prostate cancers. The use of an MRI makes ...
(Date:5/28/2015)... , May 28, 2015  Pharmaceutical ... new drugs and tests, and this is ... instruments that can assist them. This according to ... Information said instruments such as mass spectrometry, ... in the identification of drug targets and ...
Breaking Medicine Technology:MR/Ultrasound Fusion-Guided Biopsy Better Able to Detect Aggressive Prostate Cancer, New Study Says 2Report: Proteomics Research Market Reaches $1.6 Billion 2Report: Proteomics Research Market Reaches $1.6 Billion 3
... 2011 /PRNewswire/ -- MEDX, Inc., a ... the next generation T-Quest™ compact gamma camera.  The ... features expanded imaging capabilities to perform parathyroid, sentinel ... other small organ studies.  The Company also announced ...
... 6, 2011 Life Extension, a global authority on ... supplements, has launched a product featuring ChromaDex,s (CDXC.OB) pTeroPure ... food stores and natural retailers. Life Extension ... naturally found in blueberries.  Pterostilbene has been shown ...
Cached Medicine Technology:MEDX Installs Two Next Generation T-Quest™ Compact Gamma Cameras 2MEDX Installs Two Next Generation T-Quest™ Compact Gamma Cameras 3Life Extension® Launches New Product Containing ChromaDex's pTeroPure® Pterostilbene 2Life Extension® Launches New Product Containing ChromaDex's pTeroPure® Pterostilbene 3
(Date:5/30/2015)... At 73 years old, Lynn Kendall is happily ... attributes to a lifetime of being health-conscious. She passes on ... of her new book titled “ Cook for Health and ... and Longevity” features a collection of recipes and ideas for ... It is designed to encourage a lifestyle of correct eating ...
(Date:5/30/2015)... (PRWEB) May 30, 2015 Cyclist ... tour, “Wheels for the World 2015: Piles of ... to raise awareness about hemophilia and encourage individuals ... Life. , Save One Life supports nearly ... eleven developing countries through direct sponsorships, scholarships and ...
(Date:5/30/2015)... San Luis Obispo insurance ... a free analysis and consultation for anyone interested in ... Awareness Month, which was created by the non-profit organization ... States such as Polk recognize the proclamation, and use ... possibility of disability, as well as the often-overlooked need ...
(Date:5/30/2015)... 30, 2015 The iconic American actor, ... be hosting a new segment on Medical Malpractice. This ... medical malpractice in the health care field. , According ... of medical malpractice suits were filed, roughly only 20% ... settled out of court, while the remaining 30% were ...
(Date:5/30/2015)... (PRWEB) May 30, 2015 “ Milli the ... monthly AppWatch, which takes a look at the latest and ... Joe Toohey, the host of AppWatch and technology expert, conducted ... an aesthetic game that engages and educates children. , Interactive ... Unfortunately not all the content and games they are playing ...
Breaking Medicine News(10 mins):Health News:Lynn Kendall Shows How to ‘Cook for Health and Longevity’ 2Health News:Lynn Kendall Shows How to ‘Cook for Health and Longevity’ 3Health News:Barry Haarde Cycles 4,000 Miles Across the USA for Hemophilia 2Health News:San Luis Obispo Insurance Agent Susan Polk Offering Complementary Insurance Analysis In Honor Of Disability Awareness Month 2Health News:An Aesthetic Game that Engages and Educates Children was Featured on NewsWatch Television 2
... preventing disease. In the future, skin ,cancer detection may be ... is a nine-year ,survivor of melanoma. He’s lucky doctors were ... found a primary, which is what you call the skin ... skin. It had already gotten into my lymph system,” he ...
... the first one to suspect health problems, including heart ... gum disease are at higher risk for heart attacks. ... heart disease, notes the Academy of General Dentistry. There's ... "I've helped patients with heart conditions by diagnosing dental ...
... another benefit of taking aspirin. A new study shows ... week may lower their risk of leukemia by more ... 28,000 women in the Iowa Women's Health Study to ... (NSAIDs), such as ibuprofen, could protect against leukemia. ,Results ...
... shows cholesterol-lowering effects from a pill formulated with ... first placebo-controlled clinical trial to confirm the cholesterol-lowering ... populations have suggested drinking tea has health benefits ... cholesterol. Studies confirming the causal relationship between tea ...
... benefit of vitamin D. ,Each year, 200,000 women in the ... shows one form of the vitamin may enhance the effect ... mice treated with radiation alone to mice exposed to both ... treatment, the tumor volume in those women treated //with EB ...
... their tedious marathons at the basin may do more harm ... people to brush too hard for too long, to the ... Hours of tests on brushing and scrubbing volunteers have found ... to gums,// particularly if the toothbrush user presses too hard. ...
Cached Medicine News:
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: